Multicomponent Synthesis Of Triazole Derivatives Act As Potent Anti-Breast Cancer

Breast cancer continues to be a major global health challenge, driving the need for the discovery of novel and more effective therapeutic agents. Heterocyclic compounds, particularly 1,2,3-triazoles, have emerged as privileged scaffolds in medicinal chemistry due to their broad pharmacological profile, stability, and favorable drug-like properties. In this study, a series of novel triazole derivatives were synthesized through a multicomponent reaction (MCR) strategy, providing an efficient, atom-economical, and environmentally friendly approach for the rapid construction of structurally diverse molecules. The synthesized compounds were characterized using standard spectroscopic techniques (FT-IR, ¹H-NMR, ¹³C-NMR, and mass spectrometry). The triazole derivatives were then evaluated for their anticancer potential against breast cancer cell lines (e.g., MCF-7, MDA-MB-231) using MTT assay and other relevant biological evaluations. Several derivatives demonstrated significant cytotoxic activity, with selectivity towards cancerous cells compared to normal cells. Structure–activity relationship (SAR) analysis indicated that electron-donating and heteroaryl substitutions on the triazole ring enhanced anticancer potency. Overall, this study highlights the potential of multicomponent-synthesized triazole derivatives as promising anti-breast cancer agents, providing valuable insights for future drug discovery and development.